Ufp Technologies Inc (UFPT)

$256.64

+9.61

(+3.89%)

Market is closed - opens 7 PM, 28 May 2024

Insights on Ufp Technologies Inc

  • Increasing Revenue

    Revenue is up for the last 6 quarters, 91.23M → 105.00M (in $), with an average increase of 2.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 11.60M → 12.69M (in $), with an average increase of 8.6% per quarter

Performance

  • $248.58
    $257.55
    $256.64
    downward going graph

    3.14%

    Downside

    Day's Volatility :3.48%

    Upside

    0.35%

    downward going graph
  • $127.29
    $268.34
    $256.64
    downward going graph

    50.4%

    Downside

    52 Weeks Volatility :52.56%

    Upside

    4.36%

    downward going graph

Returns

PeriodUfp Technologies IncSector (Health Care)Index (Russel 2000)
3 Months
24.62%
-1.6%
0.0%
6 Months
51.53%
10.8%
0.0%
1 Year
65.06%
13.2%
0.0%
3 Years
376.58%
17.3%
-22.2%

Highlights

Market Capitalization
1.9B
Book Value
$38.46
Earnings Per Share (EPS)
6.2
PE Ratio
39.84
PEG Ratio
0.0
Wall Street Target Price
262.5
Profit Margin
11.75%
Operating Margin TTM
15.4%
Return On Assets TTM
9.68%
Return On Equity TTM
17.68%
Revenue TTM
407.3M
Revenue Per Share TTM
53.32
Quarterly Revenue Growth YOY
7.3999999999999995%
Gross Profit TTM
90.3M
EBITDA
73.4M
Diluted Eps TTM
6.2
Quarterly Earnings Growth YOY
0.29
EPS Estimate Current Year
6.63
EPS Estimate Next Year
7.19
EPS Estimate Current Quarter
1.1
EPS Estimate Next Quarter
1.35

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Ufp Technologies Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 2.28%

Current $256.64
Target $262.50

Company Financials

FY18Y/Y Change
Revenue
190.5M
↑ 28.82%
Net Income
14.3M
↑ 55.39%
Net Profit Margin
7.51%
↑ 1.28%
FY19Y/Y Change
Revenue
198.4M
↑ 4.16%
Net Income
19.8M
↑ 38.01%
Net Profit Margin
9.96%
↑ 2.45%
FY20Y/Y Change
Revenue
179.4M
↓ 9.58%
Net Income
13.4M
↓ 32.31%
Net Profit Margin
7.45%
↓ 2.51%
FY21Y/Y Change
Revenue
206.3M
↑ 15.02%
Net Income
15.9M
↑ 18.83%
Net Profit Margin
7.7%
↑ 0.25%
FY22Y/Y Change
Revenue
353.8M
↑ 71.48%
Net Income
41.8M
↑ 163.06%
Net Profit Margin
11.81%
↑ 4.11%
FY23Y/Y Change
Revenue
400.1M
↑ 13.08%
Net Income
44.9M
↑ 7.5%
Net Profit Margin
11.23%
↓ 0.58%
Q4 FY22Q/Q Change
Revenue
91.2M
↓ 5.91%
Net Income
8.5M
↓ 56.69%
Net Profit Margin
9.27%
↓ 10.88%
Q1 FY23Q/Q Change
Revenue
97.8M
↑ 7.14%
Net Income
9.7M
↑ 15.09%
Net Profit Margin
9.96%
↑ 0.69%
Q2 FY23Q/Q Change
Revenue
100.0M
↑ 2.34%
Net Income
11.9M
↑ 22.01%
Net Profit Margin
11.88%
↑ 1.92%
Q3 FY23Q/Q Change
Revenue
100.8M
↑ 0.75%
Net Income
11.7M
↓ 1.59%
Net Profit Margin
11.6%
↓ 0.28%
Q4 FY23Q/Q Change
Revenue
101.5M
↑ 0.71%
Net Income
11.6M
↓ 0.74%
Net Profit Margin
11.44%
↓ 0.16%
Q1 FY24Q/Q Change
Revenue
105.0M
↑ 3.46%
Net Income
12.7M
↑ 9.35%
Net Profit Margin
12.09%
↑ 0.65%
FY18Y/Y Change
Total Assets
189.6M
↑ 37.18%
Total Liabilities
49.1M
↑ 239.02%
FY19Y/Y Change
Total Assets
188.8M
↓ 0.44%
Total Liabilities
26.8M
↓ 45.53%
FY20Y/Y Change
Total Assets
203.2M
↑ 7.65%
Total Liabilities
26.3M
↓ 1.7%
FY21Y/Y Change
Total Assets
334.1M
↑ 64.43%
Total Liabilities
139.7M
↑ 430.9%
FY22Y/Y Change
Total Assets
377.5M
↑ 12.99%
Total Liabilities
140.0M
↑ 0.22%
FY23Y/Y Change
Total Assets
404.1M
↑ 7.04%
Total Liabilities
118.0M
↓ 15.68%
Q4 FY22Q/Q Change
Total Assets
377.5M
↓ 3.67%
Total Liabilities
140.0M
↓ 15.54%
Q1 FY23Q/Q Change
Total Assets
390.8M
↑ 3.51%
Total Liabilities
144.3M
↑ 3.07%
Q2 FY23Q/Q Change
Total Assets
398.0M
↑ 1.85%
Total Liabilities
137.7M
↓ 4.57%
Q3 FY23Q/Q Change
Total Assets
399.8M
↑ 0.46%
Total Liabilities
127.4M
↓ 7.47%
Q4 FY23Q/Q Change
Total Assets
404.1M
↑ 1.08%
Total Liabilities
118.0M
↓ 7.36%
Q1 FY24Q/Q Change
Total Assets
407.7M
↑ 0.88%
Total Liabilities
112.7M
↓ 4.56%
FY18Y/Y Change
Operating Cash Flow
21.3M
↑ 22.04%
Investing Cash Flow
-82.3M
↑ 693.53%
Financing Cash Flow
26.3M
↓ 5630.32%
FY19Y/Y Change
Operating Cash Flow
31.2M
↑ 46.48%
Investing Cash Flow
-5.8M
↓ 92.99%
Financing Cash Flow
-25.0M
↓ 194.98%
FY20Y/Y Change
Operating Cash Flow
25.0M
↓ 19.83%
Investing Cash Flow
-4.3M
↓ 26.2%
Financing Cash Flow
-285.0K
↓ 98.86%
FY21Y/Y Change
Operating Cash Flow
14.3M
↓ 42.91%
Investing Cash Flow
-101.5M
↑ 2281.11%
Financing Cash Flow
74.0M
↓ 26082.11%
FY22Y/Y Change
Operating Cash Flow
17.7M
↑ 24.14%
Investing Cash Flow
1.3M
↓ 101.27%
Financing Cash Flow
-25.9M
↓ 134.97%
Q4 FY22Q/Q Change
Operating Cash Flow
17.9M
↓ 16511.01%
Investing Cash Flow
-3.0M
↓ 108.87%
Financing Cash Flow
-20.7M
↓ 28.19%
Q1 FY23Q/Q Change
Operating Cash Flow
1.7M
↓ 90.37%
Investing Cash Flow
-2.2M
↓ 26.55%
Financing Cash Flow
2.6M
↓ 112.41%
Q2 FY23Q/Q Change
Operating Cash Flow
8.9M
↑ 415.21%
Investing Cash Flow
-2.8M
↑ 27.24%
Financing Cash Flow
-7.3M
↓ 385.34%

Technicals Summary

Sell

Neutral

Buy

Ufp Technologies Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ufp Technologies Inc
Ufp Technologies Inc
15.3%
51.53%
65.06%
376.58%
594.94%
Stryker Corporation
Stryker Corporation
-0.98%
14.14%
22.0%
31.84%
84.38%
Boston Scientific Corp.
Boston Scientific Corp.
4.32%
35.81%
49.79%
80.24%
96.7%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
2.36%
31.0%
8.07%
-6.75%
55.92%
Abbott Laboratories
Abbott Laboratories
-3.09%
1.21%
2.2%
-10.15%
37.3%
Medtronic Plc
Medtronic Plc
1.77%
4.16%
-0.25%
-34.25%
-9.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ufp Technologies Inc
Ufp Technologies Inc
39.84
39.84
0.0
6.63
0.18
0.1
NA
38.46
Stryker Corporation
Stryker Corporation
37.73
37.73
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
62.5
62.5
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.92
37.92
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.47
32.47
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.49
29.49
1.52
5.2
0.08
0.04
0.03
38.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ufp Technologies Inc
Ufp Technologies Inc
Buy
$1.9B
594.94%
39.84
11.75%
Stryker Corporation
Stryker Corporation
Buy
$125.8B
84.38%
37.73
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$109.4B
96.7%
62.5
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$53.0B
55.92%
37.92
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$182.3B
37.3%
32.47
13.96%
Medtronic Plc
Medtronic Plc
Buy
$106.7B
-9.88%
29.49
13.0%

Institutional Holdings

  • BlackRock Inc

    14.33%
  • Neuberger Berman Group LLC

    9.92%
  • Vanguard Group Inc

    6.96%
  • Renaissance Technologies Corp

    4.01%
  • Wasatch Advisors LP

    3.96%
  • State Street Corporation

    3.79%

Company Information

ufp technologies is a producer of innovative custom-engineered components, products, and specialty packaging. founded in 1963 and headquartered in newburyport, massachusetts, our company has pioneered a long list of processes and applications, has a large portfolio of active patents, and holds proprietary positions on many advanced materials from leading global suppliers. with a deep and accomplished engineering team, ufp technologies is a critical link in the value chain between raw material suppliers and oems. our team acts as an extension of customers'​ in-house research, engineering and manufacturing groups, working closely with them to solve their most complex product and packaging challenges. using foams, plastics, composites, and natural fiber materials, we design and manufacture a vast range of solutions primarily for six target markets including medical, automotive, aerospace & defense, electronics, consumer and industrial.

Organization
Ufp Technologies Inc
Employees
3093
CEO
Mr. R. Jeffrey Bailly
Industry
Process Industries

FAQs